Literature DB >> 34312447

Health-related quality of life in ICU survivors-10 years later.

José G M Hofhuis1, Augustinus J P Schrijvers2, Tjard Schermer3,4, Peter E Spronk5,6.   

Abstract

Many Intensive Care (ICU) survivors experience long lasting impairments in physical and psychological health as well as social functioning. The objective of our study was to evaluate these effects up to 10 years after ICU discharge. We performed a long-term prospective cohort study in patients admitted for longer than 48 h in a medical-surgical ICU. We evaluated health-related quality of life (HRQOL) before ICU admission using the Short-form-36 (SF-36), at ICU discharge, at hospital discharge and at 1, 2, 5 and 10 years follow up (all by patients). Changes in HRQOL were assessed based on linear mixed modeling. We included a total of 749 patients (from 2000 to 2008). During 10 years 475 (63.4%) patients had died, 125 (16.7%) patients were lost to follow up and 149 (19.9%) patients could be evaluated. The mean scores of four HRQOL dimensions (i.e., physical functioning (p < 0.001; mean 54, SD 32, effect size 0.77, 95% CI [0.54-1.0]), role-physical (p < 0.001; mean 44, SD 47, effect size 0.65, 95% CI [0.41-0.68] general health (p < 0.001; mean 52, SD 27, effect size 0.48; 95% CI 0.25-0.71) and social functioning (p < 0.001; mean 72, SD 32, effect size 0.41, 95% CI [0.19-0.64]) were still lower 10 years after ICU discharge compared with pre-admission levels (n = 149) and with an age reference population. Almost all SF-36 dimensions changed significantly over time from ICU discharge up to 10 years after ICU discharge. Over the 10 year follow up physical functioning of medical-surgical ICU survivors remains impaired compared with their pre-admission values and an age reference population. However, effect sizes showed no significant differences suggesting that surviving patients largely regained their age-specific HRQOL at 10 years.
© 2021. The Author(s).

Entities:  

Year:  2021        PMID: 34312447     DOI: 10.1038/s41598-021-94637-z

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  43 in total

Review 1.  Studying outcomes of intensive care unit survivors: measuring exposures and outcomes.

Authors:  Dale M Needham; David W Dowdy; Pedro A Mendez-Tellez; Margaret S Herridge; Peter J Pronovost
Journal:  Intensive Care Med       Date:  2005-05-21       Impact factor: 17.440

2.  Trajectories of recovery and dysfunction after acute illness, with implications for clinical trial design.

Authors:  Theodore J Iwashyna
Journal:  Am J Respir Crit Care Med       Date:  2012-08-15       Impact factor: 21.405

3.  Beyond mortality: future clinical research in acute lung injury.

Authors:  Roger G Spragg; Gordon R Bernard; William Checkley; J Randall Curtis; Ognjen Gajic; Gordon Guyatt; Jesse Hall; Elliott Israel; Manu Jain; Dale M Needham; Adrienne G Randolph; Gordon D Rubenfeld; David Schoenfeld; B Taylor Thompson; Lorraine B Ware; Duncan Young; Andrea L Harabin
Journal:  Am J Respir Crit Care Med       Date:  2010-03-11       Impact factor: 21.405

4.  The impact of disability in survivors of critical illness.

Authors:  Carol L Hodgson; Andrew A Udy; Michael Bailey; Jonathan Barrett; Rinaldo Bellomo; Tracey Bucknall; Belinda J Gabbe; Alisa M Higgins; Theodore J Iwashyna; Julian Hunt-Smith; Lynne J Murray; Paul S Myles; Jennie Ponsford; David Pilcher; Craig Walker; Meredith Young; D J Cooper
Journal:  Intensive Care Med       Date:  2017-05-22       Impact factor: 17.440

5.  Quality of life before and after intensive care.

Authors:  B H Cuthbertson; J Scott; M Strachan; M Kilonzo; L Vale
Journal:  Anaesthesia       Date:  2005-04       Impact factor: 6.955

6.  Quality of life 6 months after intensive care: results of a prospective multicenter study using a generic health status scale and a satisfaction scale.

Authors:  D Hurel; P Loirat; F Saulnier; F Nicolas; F Brivet
Journal:  Intensive Care Med       Date:  1997-03       Impact factor: 17.440

7.  ICU survivors show no decline in health-related quality of life after 5 years.

Authors:  José G M Hofhuis; Henk F van Stel; Augustinus J P Schrijvers; Johannes H Rommes; Peter E Spronk
Journal:  Intensive Care Med       Date:  2015-02-12       Impact factor: 17.440

8.  Projected incidence of mechanical ventilation in Ontario to 2026: Preparing for the aging baby boomers.

Authors:  Dale M Needham; Susan E Bronskill; Jonah R Calinawan; William J Sibbald; Peter J Pronovost; Andreas Laupacis
Journal:  Crit Care Med       Date:  2005-03       Impact factor: 7.598

9.  Determinants of long-term survival after intensive care.

Authors:  Teresa A Williams; Geoffrey J Dobb; Judith Claire Finn; Matthew William Knuiman; Elizabeth Geelhoed; K Y Lee; Steven A R Webb
Journal:  Crit Care Med       Date:  2008-05       Impact factor: 7.598

Review 10.  Recovery and outcomes after the acute respiratory distress syndrome (ARDS) in patients and their family caregivers.

Authors:  Margaret S Herridge; Marc Moss; Catherine L Hough; Ramona O Hopkins; Todd W Rice; O Joseph Bienvenu; Elie Azoulay
Journal:  Intensive Care Med       Date:  2016-03-30       Impact factor: 17.440

View more
  3 in total

Review 1.  Postacute Sequelae of COVID-19 Critical Illness.

Authors:  Kristin Schwab; Emily Schwitzer; Nida Qadir
Journal:  Crit Care Clin       Date:  2022-01-10       Impact factor: 3.879

2.  Modelling the potential acute and post-acute burden of COVID-19 under the Australian border re-opening plan.

Authors:  Mary Rose Angeles; Sithara Wanni Arachchige Dona; Huong Dieu Nguyen; Long Khanh-Dao Le; Martin Hensher
Journal:  BMC Public Health       Date:  2022-04-14       Impact factor: 3.295

3.  Long-term health-related quality of life, healthcare utilisation and back-to-work activities in intensive care unit survivors: Prospective confirmatory study from the Frisian aftercare cohort.

Authors:  Lise F E Beumeler; Anja van Wieren; Hanneke Buter; Tim van Zutphen; Gerjan J Navis; E Christiaan Boerma
Journal:  PLoS One       Date:  2022-09-07       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.